Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben S Harris

Showing results (51-60 of 267) with videos related to

Pageof 27
Sort By:
Journal of Virology|March 20, 2009
Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3GGuylaine Haché, Truus E M Abbink, Ben Berkhout, et al.
Research Square|March 30, 2023
Rapid resistance profiling of SARS-CoV-2 protease inhibitorsSeyed Arad Moghadasi, Rayhan G Biswas, Daniel A Harki, et al.
Journal of Molecular Biology|May 4, 2016
1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal StructureNadine M Shaban, Ke Shi, Ming Li, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Rapid resistance profiling of SARS-CoV-2 protease inhibitorsSeyed Arad Moghadasi, Rayhan G Biswas, Daniel A Harki, et al.
Current Biology : CB|August 7, 2004
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivoMark T Liddament, William L Brown, April J Schumacher, et al.
AIDS Research and Human Retroviruses|June 26, 2012
HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfacesJudd F Hultquist, Rebecca M McDougle, Brett D Anderson, et al.
Journal of Virology|May 14, 2010
APOBEC3G contributes to HIV-1 variation through sublethal mutagenesisHolly A Sadler, Mark D Stenglein, Reuben S Harris, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Rapid resistance profiling of SARS-CoV-2 protease inhibitorsSeyed Arad Moghadasi, Rayhan G Biswas, Daniel A Harki, et al.
The Journal of Biological Chemistry|September 30, 2015
Crystal Structure of the DNA Deaminase APOBEC3B Catalytic DomainKe Shi, Michael A Carpenter, Kayo Kurahashi, et al.
Trends in Biochemical Sciences|June 27, 2003
Immunity through DNA deaminationMichael S Neuberger, Reuben S Harris, Javier Di Noia, et al.
Pageof 27

Showing results (51-60 of 267) with videos related to

Sort By:
Pageof 27
Journal of Virology|March 20, 2009
Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3GGuylaine Haché, Truus E M Abbink, Ben Berkhout, et al.
Research Square|March 30, 2023
Rapid resistance profiling of SARS-CoV-2 protease inhibitorsSeyed Arad Moghadasi, Rayhan G Biswas, Daniel A Harki, et al.
Journal of Molecular Biology|May 4, 2016
1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal StructureNadine M Shaban, Ke Shi, Ming Li, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Rapid resistance profiling of SARS-CoV-2 protease inhibitorsSeyed Arad Moghadasi, Rayhan G Biswas, Daniel A Harki, et al.
Current Biology : CB|August 7, 2004
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivoMark T Liddament, William L Brown, April J Schumacher, et al.
AIDS Research and Human Retroviruses|June 26, 2012
HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfacesJudd F Hultquist, Rebecca M McDougle, Brett D Anderson, et al.
Journal of Virology|May 14, 2010
APOBEC3G contributes to HIV-1 variation through sublethal mutagenesisHolly A Sadler, Mark D Stenglein, Reuben S Harris, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Rapid resistance profiling of SARS-CoV-2 protease inhibitorsSeyed Arad Moghadasi, Rayhan G Biswas, Daniel A Harki, et al.
The Journal of Biological Chemistry|September 30, 2015
Crystal Structure of the DNA Deaminase APOBEC3B Catalytic DomainKe Shi, Michael A Carpenter, Kayo Kurahashi, et al.
Trends in Biochemical Sciences|June 27, 2003
Immunity through DNA deaminationMichael S Neuberger, Reuben S Harris, Javier Di Noia, et al.
Pageof 27